The clinical manifestation of GFAP astrocytopathy is complex; moreover, it can coexist with a variety of antibodies, including aquaporin-4 (AQP4) antibody and N-methyl-D-aspartate receptor (NMDAR) antibody and is, therefore, called overlap syndrome (2). This evidence concerns the gene AQP4 and overlapping connective tissue disease.